Search results
FX Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVIII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
ZYMUTEST Tissue Factor Total
Assay proposed for the measurement of total tissue factor in research application.
LIAPHEN vWF:Ag
Diagnosis of von Willebrand disease. Determination of high vWF antigen levels associated with cardiovascular diseases.
LIAPHEN Fibrinogen
Assay of fibrinogen in human citrated plasma or in cell culture supernatants.
FVIII Inhibitor Plasma (3) strong (51-200 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (3) strong (51-200 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
HEMOCLOT DTI 1 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.